US$ 21.38
gip/glp 1-agonist tirzepatide Frontiers Tirzepatide, a dual GIP/GLP-1 receptor
Description
I'm not saying do this, by the way, if you're healthy, no risk at all

It is injected once weekly at doses ranging from 0.25 mg (starting dose) to 2.0 mg (maximum dose for diabetes)

In a clinical trial, combination therapy with liraglutide and metformin shows significantly greater weight loss and lower incidence of hypoglycaemia, as compared to combination therapy with glimepiride and metformin 12,13

Another hurdle is the waiting period for noticeable results
[DOI] [PubMed] [Google Scholar] 10.Gordon S

Bottom line GLP-1 drugs can be effective tools for weight loss and blood sugar control
